Zixin Hu

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 5

Top Topics

Systematic Review

Replacement Therapy

Advanced Non Small Cell Lung Cancer

Epidermal Growth Factor Receptor

Top Venues

Journal of oncology

Cancer medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Zixin Hu, Yumin Zheng, Jiabin Zheng, Yan Wang, Jiangquan Liao, Zhening Liu, Jia Li, Huijuan Cui
Effect of body mass index and cholesterol-rich apolipoprotein-B-containing lipoproteins on clinical outcome in NSCLC patients treated with immune checkpoint inhibitors-based therapy: A retrospective analysis. Cancer medicine 13 (11) (2024)
Zixin Hu, Yumin Zheng, Jiabin Zheng, Yan Wang, Jiangquan Liao, Zhening Liu, Jia Li, Huijuan Cui
Effect of body mass index and cholesterol-rich apolipoprotein-B-containing lipoproteins on clinical outcome in NSCLC patients treated with immune checkpoint inhibitors-based therapy: A retrospective analysis. Cancer medicine 13 (11) (2024)
Huijing Dong, Chongxiang Xue, Yumin Zheng, Xu Zhang, Zixin Hu, Xingyu Lu, Yixuan Yu, Jia Li, Kexin Tan, Huijuan Cui
Efficacy and Safety of Immune Checkpoint Inhibitors in Patients with Cancer and Hepatitis B or C: A Systematic Review and Meta-Analysis. Journal of oncology 2023 (2023)
Huijing Dong, Chongxiang Xue, Yumin Zheng, Xu Zhang, Zixin Hu, Xingyu Lu, Yixuan Yu, Jia Li, Kexin Tan, Huijuan Cui
Efficacy and Safety of Immune Checkpoint Inhibitors in Patients with Cancer and Hepatitis B or C: A Systematic Review and Meta-Analysis. Journal of oncology 2023 (2023)
Zixin Hu, Chongxiang Xue, Jiabin Zheng, Xingyu Lu, Jia Li, Huijing Dong, Yixuan Yu, Xu Zhang, Kexin Tan, Huijuan Cui
Hyper-Methylated Hub Genes of T-Cell Receptor Signaling Predict a Poor Clinical Outcome in Lung Adenocarcinoma. Journal of oncology 2022 (2022)